Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supporting Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wiczkowski, W.
Right arrow Articles by Piskula, M. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiczkowski, W.
Right arrow Articles by Piskula, M. K.
© 2008 American Society for Nutrition J. Nutr. 138:885-888, May 2008


Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Quercetin from Shallots (Allium cepa L. var. aggregatum) Is More Bioavailable Than Its Glucosides1–3,

Wieslaw Wiczkowski, Jerzy Romaszko, Adam Bucinski4, Dorota Szawara-Nowak, Joanna Honke, Henryk Zielinski and Mariusz K. Piskula*

Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, Tuwima 10, 10-747 Olsztyn, Poland

* To whom correspondence should be addressed. E-mail: empi{at}pan.olsztyn.pl.

The lipophilic character of quercetin suggests that it can cross enterocyte membranes via simple diffusion. Therefore, it should be more bioavailable than its glucosides, which require preliminary hydrolysis or active transport for absorption. However, the published human studies show that quercetin is less bioavailable than its glucosides. Assuming that low bioavailability of quercetin aglycone provided to humans as a pure substance is the result of its low solubility in the digestive tract, we studied its bioavailability from dietary sources in which quercetin was dispersed in the food matrix. In a randomized crossover study, 9 volunteers took a single dose of either shallot flesh (99.2% quercetin glucosides and 0.8% quercetin aglycone) or dry shallot skin (83.3% quercetin aglycone and 16.7% quercetin glucosides), providing 1.4 mg quercetin per kg of body weight. Blood samples were collected before and after consumption of shallot preparations. Plasma quercetin was measured on HPLC with electrochemical detection after plasma enzymatic treatment. The maximum plasma quercetin concentration of 1.02 ± 0.13 µmol/L was reached at 2.33 ± 0.50 h after shallot flesh consumption compared with 3.95 ± 0.62 µmol/L at 2.78 ± 0.15 h after dry skin consumption. The area under the concentration-time curve after dry skin consumption was 47.23 ± 7.53 µmol·h–1·L–1 and was significantly higher than that after shallot flesh intake (22.23 ± 2.32 µmol·h–1·L–1). When provided along with dietary sources, quercetin aglycone is more bioavailable than its glucosides in humans. Results point to the food matrix as a key factor.








Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]